UBS has downgraded Charles River Laboratories (NYSE:CRL) to neutral from buy, citing concerns about decelerating sales growth ...

UBS Group AG has removed Credit Suisse’s signs at its one-time arch-rival’s former headquarters in Zurich, replacing them ...

A group of activists has been campaigning to bar UBS from the U.S. pension market given the "serious financial crimes" ...

JP Morgan and UBS have topped the charts for mergers and acquisitions (M&A) financial advisers in the Asia-Pacific region for ...

Kelvin Tay, Regional CIO at UBS Global Wealth Management, talks about how President-elect Trump's policy suggestions will ...

Emerging-market equities and currencies are vulnerable to further losses as the recent selloff hasn’t fully priced in risks ...

UBS could be seen as being too big for Switzerland following its takeover of Credit Suisse, former Swiss Finance Minister ...

The Siegel-WisdomTree Model Portfolios are now available on the UBS Financial Services Inc. separately managed account ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 27.24% ...

The deceleration is underpinned by a long-term moderation in credit growth, foreign direct investment, export competitiveness ...

UBS has adjusted its price target for Azelis upward, from €19 to €22, reflecting a 1% increase in expected earnings per share ...

According to UBS, APL Apollo Tubes is poised to sustain its growth momentum, driven by increased customer adoption of ...